Abstract
The methods outlined in Subheading 3. provide a logical sequence of assays with which to evaluate the biochemical and biological properties of potential FPTase inhibitors. The clinical predictability of these assays must await the evaluation of one or more of these compounds in humans.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have